Lazaropoulos, Michael P. https://orcid.org/0000-0002-3872-3744
Lynch, David R. https://orcid.org/0000-0001-7168-214X
Article History
Received: 27 March 2026
Accepted: 10 May 2026
First Online: 29 June 2026
Declarations
:
: This work was supported by Friedreich ataxia Research Alliance grants to DRL, and the US Department of Defense grants (USAMRAA) HT94252510542 (DRL).
: Michael Lazaropoulos declares that he has no conflicts of interest that might be relevant to the contents of this manuscript. Dr Lynch receives grants to perform clinical trials for Solid, Larimar, Biogen, and PTC, and has previously received grants from Neurocrine and Design.
: Not applicable.
: Not applicable.
: MPL and DRL are responsible for the conceptualization, writing, and editing of the text and figures of this article. All authors have read and approved the final version.
: Not applicable.
: Not applicable.